06Nov/17
Actemra/RoActemra® Is Approved by FDA for the Treatment of Cytokine Release Syndrome Caused by CAR-T Therapy
Actemra/RoActemra® is the first FDA approved drug for treatment of serious or fatal cytokine release syndrome (CRS) caused by CAR-T therapy; CAR-T cell therapy is an immunotherapy used to treat certain typesRead More…